{
    "name": "Progabide",
    "smiles": "O=C2C=CC(F)=C/C2=C(NCCCC(N)=O)c1ccc(Cl)cc1",
    "csid": 4514729,
    "link": "http://www.drugbank.ca/drugs/DB00837",
    "source": "DrugBank",
    "Reason": "1-ethylpiperazine-2,3-dione base, with a melting point around 106\u00b0C, due to the presence of two carbonyl groups, which can form hydrogen bonds and rigidify the structure, raising the melting point by approximately +10\u00b0C each. The 1-ethyl substitution tends to lower the melting point compared to piperazine, as it creates a more asymmetric structure, reducing the crystal lattice stability, which might decrease the melting point by approximately -10\u00b0C. The methoxy group introduces additional hydrogen bonding potential, estimated at around +5\u00b0C. The fluorine atom raises the melting point due to the increased molecular weight and the capacity for hydrogen bonding, estimated at around +5\u00b0C. The chlorine atom introduces additional rigidity, estimated at around +5\u00b0C. The presence of a dioxane-like bridging moiety adds rigidity and likely contributes more significantly than a simple ether, estimated at around +5\u00b0C for this structural feature.",
    "mpC": 134.0,
    "Prediction(integer)": 116.0,
    "Abs error": 6.0
}